Copyright
©2014 Baishideng Publishing Group Co.
World J Clin Urol. Mar 24, 2014; 3(1): 31-37
Published online Mar 24, 2014. doi: 10.5410/wjcu.v3.i1.31
Published online Mar 24, 2014. doi: 10.5410/wjcu.v3.i1.31
Therapy | Therapeutic activity and indication |
Oral treatment with potassium para- aminobenzoate | Reduction in penile plaque size and penile pain as well as penile curvature stabilization |
Oral treatment with vitamin E and tamoxifen | Not associated with significant reduction in penile curvature, plaque size or penile pain |
Other oral treatments (acetyl esters of carnitine, pentoxifylline) | Not recommended |
Intralesional treatment with verapamil | No statistically significant differences in plaque size, penile curvature, penile pain |
Intralesional treatment with steroids | Not associated with significant reduction in penile curvature, plaque size or penile pain |
Intralesional treatment with interferon | Improve Penile curvature, plaque size and density, and pain |
Intralesional treatment with clostridial collagenase | Significant decreases in the deviation angle, plaque width and plaque length |
Iontophoresis with verapamil 5 mg and dexamethasone 8 mg | Improve penile curvature and plaque size |
Extracorporeal shock-wave treatment | Beneficial for penile pain and stabilization of plaque |
Topical verapamil gel 15% | Improve penile curvature and plaque size |
Penile traction devices and vacuum devices | Reduce penile deformity and increase penile length |
Combination therapies | Preliminary evidences to be clarified |
- Citation: Verze P, Arcaniolo D, Cai T, Franco M, Rocca RL, Acquaviva M, Spirito L, Bochorishvili A, Mirone V. Systematic review of the non surgical management of Peyronie's disease. World J Clin Urol 2014; 3(1): 31-37
- URL: https://www.wjgnet.com/2219-2816/full/v3/i1/31.htm
- DOI: https://dx.doi.org/10.5410/wjcu.v3.i1.31